The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model

Journal of Urology

Volumn 156, Issue 3, 1996, Pages 1174-1179

  Davol, Pamela ^a   Frackelton Jr , A Raymond ^a,b  

^a BROWN UNIVERSITY   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

basic; fibroblast growth factor; heterologous; immunotoxins; prostatic neoplasms; transplantation

Indexed keywords

MITOTOXIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; SAPORIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUANTITATIVE DIAGNOSIS;

EID: 0029738732     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65745-8     Document Type: Article

References (29)

1. Hickey, D., Cant, J. and Soloway, M. S.: Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who failed androgen deprivation. Urology, 31: 38, 1988.
2. Yagoda, A. and Petrylak, D.: Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer, 71: 1098, 1993.
3. Mansson, P., Adams, P., Kan, M. and McKeehan, W. L.: Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res., 49: 2485, 1989.
4. Matuo, Y., McKeehan, W. L., Yan, G. C., Nikolaropoulos, S., Adams, P. S., Fukabori, Y., Yamanaka, H. and Gaudreau, J.: Potential role of HBGF (FGF) and TGF-beta on prostate growth. Adv. Exp. Med. Biol., 324: 107, 1992.
5. Nakamoto, T., Chawnshang, C., Ankun, L. and Chodak, G. W.: Basic fibroblast growth factor in human prostate cancer cells. Cancer Res., 52: 571, 1992.
6. Myers, C., Cooper, M., Stein, C., LaRocca, R., Walther, M. M., Weiss, G., Choyke, P., Dawson, N., Steinberg, S., Uhrich, M. M., Cassidy, J., Kohler, D. R., Trepel, J. and Linehan, W. M.: Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J. Clin. Oncol., 10: 881, 1992.
7. Eisenberger, M. A., Reyno, L. M., Jodrell, D. I., Sinibaldi, V. J., Tkaczuk, K. H., Sridhara, R., Zuhowski, E. G., Lowitt, M. H., Jacobs, S. C. and Egorin, M. J.: Suramin, an active drug for prostate cancer: interim observations in a Phase I trial. J. Natl. Cancer Inst., 85: 611, 1993.
8. Lappi, D. A., Ying, W., Barthelemy, I., Martineau, D., Prieto, I., Benatti, L., Soria, M., and Baird, A.: Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein. J. Biol. Chem., 269: 12552, 1994.
9. Lappi, D. A., and Baird, A.: Mitotoxins: growth factor-targeted cytotoxic molecules. Prog. Growth Factor Res., 2: 223, 1991.
10. Beitz, J. G., Davol, P., Clark, J., Kato, J., Medina, M., Frackelton, A. R., Jr., Lappi, D. A., Baird, A., and Calabresi, P.: Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. Cancer Res., 52: 227, 1992.
11. Davol, P., Beitz, J. G., and Frackelton, A. R., Jr.: Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell line. J. Invest. Dermatol., 104: 916, 1995.
12. Davol, P., Beitz, J. G., Mohler, M., Ying, W., Cook, J., Lappi, D. A. and Frackelton, A. R., Jr.: Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model. Cancer, 76: 79, 1995.
13. Lappi, D. A., Martineau, D. and Baird, A.: Biological and chemical characterization of basic fibroblast growth factor-saporin mitotoxin. Biochem. Biophys. Res. Commun., 160: 917, 1989.
14. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H. and Paulson, D. F.: Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer, 21: 274, 1978.
15. Geran, R. I., Greenberg, N. H., Macdonald, M. M., Schumacher, A. M. and Abbott, B. J.: Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep., part 3, 3:1, 1972.
16. O'Hare, M., Brown, A. N., Hussain, K., Gebhardt, A., Watson, G., Roberts, L. M., Vitetta, E. S., Thorpe, P. E. and Lord, J. M.: Cytotoxicity of a recombinant ricin A-chain fusion protein containing a proteolytically-cleavable spacer sequence. F. E. B. S. Lett., 273: 200, 1990.
17. Halaban, R., Kwon, B. S., Ghosh, S., Delli Bovi, P. and Baird, A.: bFGF as an autocrine growth factor for human melanomas. Oncogene Res., 3: 177, 1988.
18. Morrison, R. S., Gross, J. L., Herblin, W. F., Relly, T. M., LaSala, P. T., Alterman, R. L., Moskal, J. R., Kornblith, P. L. and Dexter, D. L.: Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res., 50: 2524, 1990.
19. Zagzag, D., Miller, D. C., Sato, Y., Rifkin, D. B. and Burnstein, D. E.: Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res., 50: 7393, 1990.
20. Johnson, D. E. and Williams, L. T.: Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60: 1, 1993.
21. Givol, D. and Yayon, A.: Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. F. A. S. E. B. J., 6: 3362, 1992.
22. Rogelj, S., Weinberg, R. A., Fanning, P. and Klagsbrun, M.: Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature, 331: 173, 1988.
23. Sasada, R., Kurokawa, T., Iwane, M. and Igarashi, K.: Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA. Mol. Cell Biol., 8: 588, 1988.
24. Yan, G., Fukabori, Y., McBride, G., Nikolaropoulous, S. and McKeehan, W. L.: Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell Biol., 13: 4513, 1993.
25. Whalen, G. F., Shing, Y. and Folkman, J.: The fate of intravenously administered basic fibroblast growth factor and the effect of heparin. Growth Factors, 1: 157, 1989.
26. David, T., Tassin, J., Lappi, D. A., Baird, A. and Courtois, Y.: Biphasic effect of the mitotoxin bFGF-saporin on bovine lens epithelial cell growth: effect of cell density and extracellular matrix. J. Cell. Physiol., 153: 483, 1992.
27. Folkman, J., Watson, K., Ingber, D. and Hanahan, D.: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 339: 58, 1989.
28. Lindner, V., Lappi, D. A., Baird, A., Majack, R. A. and Reidy, M. A.: Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res., 68: 106, 1991.
29. Sato, Y. and Rifkin, D. B.: Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell Biol., 107: 1199, 1988.